Together Pharma Ltd (TLV:TGTR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 308.30
-3.50 (-1.12%)
Mar 9, 2026, 5:24 PM IDT
Together Pharma Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 53 | 54 | 34 | 19 | 68 | 136 | Upgrade
|
| Market Cap Growth | -10.64% | 58.74% | 82.58% | -72.51% | -50.07% | -23.85% | Upgrade
|
| Enterprise Value | 97 | 112 | 92 | 61 | 138 | 177 | Upgrade
|
| Last Close Price | 3.08 | 3.92 | 3.88 | 2.48 | 10.62 | 24.31 | Upgrade
|
| PE Ratio | - | - | - | - | - | 19.02 | Upgrade
|
| PS Ratio | 0.49 | 0.56 | 0.38 | 0.60 | 5.65 | 12.12 | Upgrade
|
| PB Ratio | 1.08 | 1.42 | -13.36 | 6.18 | 2.64 | 9.24 | Upgrade
|
| P/TBV Ratio | 2.56 | 6.29 | - | - | - | - | Upgrade
|
| P/FCF Ratio | 5.80 | 39.38 | 2.44 | - | - | - | Upgrade
|
| P/OCF Ratio | 5.52 | 18.99 | 2.30 | - | - | - | Upgrade
|
| EV/Sales Ratio | 0.88 | 1.16 | 1.01 | 1.97 | 11.50 | 15.80 | Upgrade
|
| EV/EBITDA Ratio | 13.18 | 12.52 | 3.33 | - | - | 8.63 | Upgrade
|
| EV/EBIT Ratio | 257.55 | 34.17 | 4.16 | - | - | 10.66 | Upgrade
|
| EV/FCF Ratio | 10.48 | 81.38 | 6.58 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.01 | 1.66 | -21.48 | 19.88 | 3.32 | 3.89 | Upgrade
|
| Debt / EBITDA Ratio | 6.80 | 6.29 | 1.92 | - | - | 2.74 | Upgrade
|
| Debt / FCF Ratio | 5.41 | 46.26 | 3.92 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.81 | 1.44 | -20.07 | 18.13 | 3.12 | 3.50 | Upgrade
|
| Net Debt / EBITDA Ratio | 6.55 | 6.17 | 1.85 | -3.81 | -13.08 | 2.51 | Upgrade
|
| Net Debt / FCF Ratio | 4.38 | 40.12 | 3.67 | -3.89 | -3.98 | -2.19 | Upgrade
|
| Asset Turnover | 0.71 | 0.67 | 0.68 | 0.22 | 0.09 | 0.12 | Upgrade
|
| Inventory Turnover | 1.54 | 1.41 | 1.13 | 0.82 | 0.34 | - | Upgrade
|
| Quick Ratio | 0.43 | 0.36 | 0.27 | 0.29 | 0.09 | 0.37 | Upgrade
|
| Current Ratio | 1.11 | 1.07 | 1.17 | 1.25 | 1.32 | 2.12 | Upgrade
|
| Return on Equity (ROE) | -14.88% | -9.09% | -1076.01% | -246.99% | -74.80% | 1175.31% | Upgrade
|
| Return on Assets (ROA) | 0.15% | 1.43% | 10.29% | -8.57% | -5.04% | 10.77% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.42% | 4.61% | -68.34% | -24.14% | -13.31% | 45.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.50% | 4.80% | 28.90% | -24.00% | -12.40% | 16.00% | Upgrade
|
| Earnings Yield | -12.27% | -2.17% | -12.66% | -179.57% | -20.28% | 5.26% | Upgrade
|
| FCF Yield | 17.23% | 2.54% | 40.97% | -75.34% | -29.70% | -17.24% | Upgrade
|
| Buyback Yield / Dilution | -41.07% | -41.39% | -7.81% | -18.96% | -18.76% | -14.93% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.